Search research articles
Contact Us
Filters
Showing results (131-140 of 137) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 137 results.
The Lancet. Oncology
|
December 1, 2022
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
Victor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, et al.
Carcinogenesis
|
February 14, 2014
HPV-associated lung cancers: an international pooled analysis
Camille Ragin, Monisola Obikoya-Malomo, Sungjin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2019
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer
Gillianne G Y Lai, Tse Hui Lim, John Lim, et al.
Cell Reports. Medicine
|
May 24, 2025
Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypes
Eugenia Li Ling Yeo, Boon Hao Hong, Shi Hui Tay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2021
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
Khi Pin Chua, Yvonne H F Teng, Aaron C Tan, et al.
Nature Genetics
|
February 5, 2020
Genomic landscape of lung adenocarcinoma in East Asians
Jianbin Chen, Hechuan Yang, Audrey Su Min Teo, et al.
Nature Medicine
|
March 20, 2012
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
King Pan Ng, Axel M Hillmer, Charles T H Chuah, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 137) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 137 results.
The Lancet. Oncology
|
December 1, 2022
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
Victor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, et al.
Carcinogenesis
|
February 14, 2014
HPV-associated lung cancers: an international pooled analysis
Camille Ragin, Monisola Obikoya-Malomo, Sungjin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2019
Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer
Gillianne G Y Lai, Tse Hui Lim, John Lim, et al.
Cell Reports. Medicine
|
May 24, 2025
Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypes
Eugenia Li Ling Yeo, Boon Hao Hong, Shi Hui Tay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2021
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
Khi Pin Chua, Yvonne H F Teng, Aaron C Tan, et al.
Nature Genetics
|
February 5, 2020
Genomic landscape of lung adenocarcinoma in East Asians
Jianbin Chen, Hechuan Yang, Audrey Su Min Teo, et al.
Nature Medicine
|
March 20, 2012
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
King Pan Ng, Axel M Hillmer, Charles T H Chuah, et al.
Page
of 14